Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion

European Respiratory Journal

Volumn 33, Issue 3, 2009, Pages 625-633

  Muhlfeld C ^a   Schaefer, I M ^a   Becker, L ^a   Bussinger, C ^a   Vollroth, M ^b   Bosch, A ^c   Nagib, R ^b   Madershahian, N ^d   Richter, J ^c   Wahlers, T ^d   Wittwer, T ^d   Ochs, M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Electron microscopy; Ischaemia; Lung transplantation; Reperfusion; Stereology; Surfactant

Indexed keywords

LUNG SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROL GROUP; ELECTRON MICROSCOPE; EXPERIMENTAL RAT; ISCHEMIA; LUNG ARTERY PRESSURE; LUNG GAS EXCHANGE; LUNG INJURY; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; REPERFUSION; STEREOLOGY;

ANIMALS; CITRATES; EDEMA; HUMANS; ISCHEMIA; LUNG; LUNG INJURY; MALE; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, TRANSMISSION; PERFUSION; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 61649119340     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00024108     Document Type: Article

References (46)

1. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454-1459.
2. Mulligan MS. Primary graft dysfunction following lung transplantation: pathogenesis and impact on early and late outcomes. In: Lynch III JP, Ross DJ, eds. Lung and Heart-Lung Transplantation. New York, Taylor & Francis, 2006; pp. 437-464.
3. Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 71: 1312-1316.
4. Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007; 175: 507-513.
5. Fehrenbach H, Schepelmann D, Albes JM, et al. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec 1999; 255: 84-89.
6. Mühlfeld C, Müller K, Pallesen LP, et al. Impact of preservation solution on the extent of edema formation and blood-air barrier damage in experimental lung transplantation. Anat Rec 2007; 290: 491-500.
7. Lewis JF, Novick RJ, Veldhuizen RAW. Surfactant in lung injury and lung transplantation. New York, Springer, 1997.
8. Ochs M, Nenadic I, Fehrenbach A, et al. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med 1999; 160: 718-724.
9. Ochs M, Fehrenbach H, Nenadic I, et al. Preservation of intraalveolar surfactant in a rat lung ischaemia/reperfusion injury model. Eur Respir J 2000; 15: 526-531.
10. De Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490-511.
11. Lewis JF, Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003; 65: 613-642.
12. Novick RJ, MacDonald J, Veldhuizen RA, et al. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 1996; 154: 98-104.
13. Buchanan SA, Mauney MC, Parekh VI, et al. Intratracheal surfactant administration preserves airway compliance during lung reperfusion. Ann Thorac Surg 1996; 62: 1617-1621.
14. Erasmus ME, Petersen AH, Hofstede G, et al. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 1996; 153: 665-670.
15. Novick RJ, Gilpin AA, Gehman KE, et al. Mitigation of injury in canine lung grafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg 1997; 113: 342-353.
16. Hausen B, Rohde R, Hewitt CW, et al. Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 1997; 113: 1050-1058.
17. Hohlfeld JM, Strüber M, Ahlf K, et al. Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 1999; 13: 1037-1043.
18. Erasmus ME, Hofstede GJ, Petersen AH, et al. SP-A-enriched surfactant for treatment of rat lung transplants with SP-A deficiency after storage and reperfusion. Transplantation 2002; 73: 348-352.
19. Friedrich I, Börgermann J, Splittgerber FH, et al. Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation. J Thorac Cardiovasc Surg 2004; 127: 335-343.
20. Günther A, Balser M, Schmidt R, et al. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. J Thorac Cardiovasc Surg 2004; 127: 344-354.
21. Van der Kaaij NP, Haitsma JJ, Kluin J, et al. Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung. Eur J Cardiothorac Surg 2005; 27: 774-782.
22. Strüber M, Hirt SW, Cremer J, Harringer W, Haverich A. Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 1999; 25: 862-864.
23. Strüber M, Fischer S, Niedermeyer J, et al. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg 2007; 133: 1620-1625.
24. Kermeen FD, McNeil KD, Fraser JF, et al. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant 2007; 26: 850-856.
25. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996; 62: 302-314.
26. Novick RJ. Innovative techniques to enhance lung preservation. J Thorac Cardiovasc Surg 2002; 123: 3-5.
27. Ochs M. A brief update on lung stereology. J Microsc 2006; 222: 188-200.
28. Ochs M. Stereological analysis of acute lung injury. Eur Respir Rev 2006; 15: 115-121.
29. National Institutes of Health. Guide for the Care and Use of Laboratory Animals; NIH Publication 85-23. Bethesda, National Institutes of Health, 1996.
30. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992; 18: 319-321.
31. Fukuse T, Albes JM, Takahashi Y, Brandes H, Hausen B, Schäfers HJ. Influence of red blood cells on lung function in an ex vivo rat heart-lung model. J Surg Res 1995; 59: 399-404.
32. Fehrenbach H, Ochs M. Studying lung ultrastructure: In: Uhlig S, Taylor AE, eds. Methods in Pulmonary Research. Basel, Birkhäuser, 1998; pp. 429-454..
33. Mühlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, Ochs M. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol 2007; 4: 11.
34. Weibel ER, Hsia CCW, Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 2007; 102: 459-467.
35. Veldhuizen RA, Lee D, Sandler D, et al. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 1993; 148: 208-215.
36. Erasmus ME, Petersen AH, Bambang Oetomo S, Prop J. The function of surfactant is impaired during the reimplantation response in rat lung transplantation. J Heart Lung Transplant 1994; 13: 791-802.
37. Andrade RS, Solien EE, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RM. Surfactant dysfunction in lung preservation. Transplantation 1995; 60: 536-541.
38. Casals C, Varela A, Ruano ML, et al. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am J Respir Crit Care Med 1998; 157: 43-49.
39. Hohlfeld JM, Tiryaki E, Hamm H, et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 1998; 158: 706-712.
40. Maitra G, Inchley K, Novick RJ, Veldhuizen RAW, Lewis JF, Possmayer F. Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol 2002; 282: L67-L74.
41. Van Raemdonck D, Strüber M, Venuta F, Vlasselaers D, Wisser W, Erasmus ME. Strategies in the prevention and the treatment of ischaemia-reperfusion injury after lung transplantation. Eur Respir Mon 2004; 29: 66-88.
42. Sadovski J, Kuchenbuch T, Ruppert C, et al. Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts. Eur Respir J 2008; 31: 21-28.
43. Strüber M, Hohlfeld JM, Fraund S, Kim P, Warnecke G, Haverich A. Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg 2000; 120: 566-572.
44. Wittwer T, Albes JM, Fehrenbach A, et al. Experimental lung preservation with Perfadex: effect of the NO-donor nitroglycerin on postischemic outcome. J Thorac Cardiovasc Surg 2003; 125: 1208-1216.
45. Saugstad OD, Curstedt T, Halliday HL, Robertson B, Speer CP. Surfactant replacement therapy from 1986 to 2006: a 20-year success story. Biol Neonate 2006; 89: 282-283.
46. Fehrenbach A, Fehrenbach H, Wittwer T, Ochs M, Wahlers T, Richter J. Evaluation of pulmonary edema: stereological versus gravimetrical analysis. Eur Surg Res 2001; 33: 270-278.